K. Rohrmann

524 total citations
9 papers, 405 citations indexed

About

K. Rohrmann is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, K. Rohrmann has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in K. Rohrmann's work include Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Renal and related cancers (3 papers). K. Rohrmann is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Renal and related cancers (3 papers). K. Rohrmann collaborates with scholars based in Germany. K. Rohrmann's co-authors include Michael Siebels, Christian G. Stief, Julia Schleypen, Dolores J. Schendel, Christine S. Falk, Heike Pohla, Nicolas Haseke, Michael Staehler, R. Oberneder and Manfred Kindler and has published in prestigious journals such as Clinical Cancer Research, The Journal of Urology and International Journal of Cancer.

In The Last Decade

K. Rohrmann

9 papers receiving 402 citations

Peers

K. Rohrmann

IMMUN

ONCOL

MB

PRM

CR

Leticia Tetteh United States

Amy E. Hanna United States

María González Cao Spain

Sonia Garofalo Italy

Lars D. Engstrom United States

Nikolaos Ioannou United Kingdom

Jianling Zou China

Mai Ashizawa Japan

Roy Elias United States

Gen Lin China

Leticia Tetteh United States

K. Rohrmann

149 ×0.8

IMMUN

306 ×1.8

ONCOL

197 ×1.2

MB

112 ×1.1

PRM

23 ×0.3

CR

Citations per year, relative to K. Rohrmann K. Rohrmann (= 1×) peers Leticia Tetteh

Countries citing papers authored by K. Rohrmann

Since Specialization

Citations

This map shows the geographic impact of K. Rohrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Rohrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Rohrmann more than expected).

Fields of papers citing papers by K. Rohrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Rohrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Rohrmann. The network helps show where K. Rohrmann may publish in the future.

Co-authorship network of co-authors of K. Rohrmann

This figure shows the co-authorship network connecting the top 25 collaborators of K. Rohrmann. A scholar is included among the top collaborators of K. Rohrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Rohrmann. K. Rohrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Rohrmann, K., et al.. (2021). MP09-04 iTind FOR THE TREATMENT OF LUTS SECONDARY TO BPH IN POLYMORBID PATIENTS: THOSE IN ACUTE URINARY RETENTION AND ON ANTI-COAGULANTS. The Journal of Urology. 206(Supplement 3). 1 indexed citations

2.

Siebels, Michael, K. Rohrmann, R. Oberneder, et al.. (2010). A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World Journal of Urology. 29(1). 121–126. 85 indexed citations

3.

Adam, C., Anno Graser, Walter Koch, et al.. (2006). Symphysitis following transrectal biopsy of the prostate. International Journal of Urology. 13(6). 832–833. 8 indexed citations

4.

Schleypen, Julia, Nicole Baur, Robert Kammerer, et al.. (2006). Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma. Clinical Cancer Research. 12(3). 718–725. 112 indexed citations

5.

Rohrmann, K., et al.. (2005). Immunotherapy in metastatic renal cell carcinoma. World Journal of Urology. 23(3). 196–201. 28 indexed citations

6.

Staehler, Michael, K. Rohrmann, Alexander Bachmann, et al.. (2005). Therapeutic approaches in metastatic renal cell carcinoma. British Journal of Urology. 95(8). 1153–1161. 12 indexed citations

7.

Staehler, Michael, K. Rohrmann, Nicolas Haseke, Christian G. Stief, & Michael Siebels. (2005). Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma. Current Drug Targets. 6(7). 835–846. 59 indexed citations

8.

Rohrmann, K., Julia Schleypen, C. Adam, A Hofstetter, & Michael Siebels. (2004). Komplette Remission beim pulmonal metastasierten Nierenzellkarzinom durch Inhalationstherapie mit Interleukin-2 nach erfolgloser systemischer Immunchemotherapie. Der Urologe. 43(10). 1271–1274. 3 indexed citations

9.

Schleypen, Julia, et al.. (2003). Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. International Journal of Cancer. 106(6). 905–912. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact